In people with obesity and prediabetes, losing weight through diet improves certain measures of insulin sensitivity but does not lower blood sugar levels or improve all insulin sensitivity markers,...

Pro

Against

Mechanism

Synthesis from 1 study

How it works

A specific signal in the body, triggered by a drug but not by dieting, tells the liver to make less sugar and helps muscles and liver use insulin better — lowering blood sugar without needing more insulin. Losing weight helps a little with insulin, but it doesn’t activate this same signal, so blood...

Most probable mechanism

In Simple Terms

When a specific hormone-like compound binds to receptors on the liver, muscle, and pancreas, it makes these tissues more responsive to insulin and stops the liver from releasing too much sugar into the blood. This happens even before any weight loss occurs, and it lowers blood sugar levels without needing the body to produce more insulin. Diet-induced weight loss improves some measures of insulin sensitivity but does not trigger this same effect on the liver or reduce blood sugar after meals.

Causal chain

A hormone-like compound binds to GLP-1 receptors on hepatocytes, skeletal muscle cells, and pancreatic alpha and beta cells

Verified by multiple studies

which leads to

Receptor activation triggers intracellular signaling that enhances insulin sensitivity in liver and muscle tissues, increasing glucose uptake and reducing insulin demand

Verified by multiple studies

which leads to

GLP-1 receptor activation directly inhibits glucagon secretion from pancreatic alpha cells, reducing the signal that tells the liver to produce glucose

Verified by multiple studies

which leads to

Reduced glucagon and enhanced insulin sensitivity together suppress hepatic glucose production during fasting and after meals

Verified by multiple studies

which leads to

These changes lower fasting and postprandial blood glucose levels and improve measures of insulin sensitivity that reflect whole-body and peripheral function

Verified by multiple studies

Evidence from Studies

Supporting (1)

Community contributions welcome

Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes.

Randomized Controlled Trial

Human

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes.

Score: 89

DOI: 10.2337/db23-0356

Similar Assertions

In people with obesity and prediabetes, a daily dose of liraglutide improves how the body responds to insulin within two weeks, before any significant weight loss occurs, and this improvement is blocked when the GLP-1 receptor is inhibited.

81%

In adults with obesity and prediabetes, losing weight through calorie reduction maintains muscle mass, but taking 1.8 mg of liraglutide daily causes muscle mass to decrease.

79%

In people with obesity and prediabetes, losing weight through diet improves how the liver responds to insulin, but does not improve how muscles and other tissues respond to insulin.

78%

In adults with obesity and prediabetes, taking 1.8 mg of liraglutide daily increases feelings of fullness and reduces self-reported desire to eat later, but does not lower the actual amount of calories consumed compared to dieting alone.

78%

In adults with obesity and prediabetes, a 14-week diet creating a 390 kcal daily deficit leads to more weight loss and a greater improvement in body fat-to-muscle ratio than daily 1.8 mg liraglutide.

78%